Egypt-based health tech startup Dileny Technologies (DilenyTech) LLC secured a $160,00 non-equity grant. The fund will be used to expand its AI-Enabled platform to improve and expedite breast cancer detection.
Breast cancer has been the second most common type of cancer with about 2 million new cases per year worldwide. More than 400 million breast examinations are performed annually while there are insufficient radiologists to report those examinations and notify patients in a timely manner. “DilenyTech aims to revolutionize breast cancer screening and diagnostic workflow via providing innovative AI assistance for more accurate breast cancer detection and expedited reporting.
Thousands of healthcare professionals can access our online platform anytime/anywhere. This shall reduce patients’ suffering due to long waiting time as well as inaccurate diagnosis,” said Dr. Ahmed Ehab Mahmoud, Founder, and chief innovation officer.